|
|
via Benigno Crespi 17
Milano, ITY 20159 Italy
phone:+39-02-69969711-509
fax:(39) 02 63321
|
|
| Symbol |
SORN.MI |
| Exchange |
MTA |
| Founded |
0 |
| Employees |
|
|
|
| www.sorin.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Products used to treat cardiovascular and renal diseases. |
|
| Management |
| Rosario Bifulco, President; Andr? Michel Ballester, Chief Executive Officer; St?phane Bessette, Vice President Human Resources; Michel Darnaud, President Cardiopulmonary BU and Intercontinental; Stefano Di Lullo, President CRM BU, and Heart Valves BU; Demetrio Mauro, Vice President Finance, Chief Financial Officer; Brian Sheridan, General Counsel |
| |
|
|
|
|
|
|
|
| Keywords |
| technology, cardiovascular, renal, diseases, artificial, Cardiology, cardiac, heart, valves, annuloplasty, crm, pacemaker, defibrillators, holter, vascular, bellco, stents, advamed |
|
|
|
| Description |
|
The Sorin Group is a medical technology leader focused on the development of products used to treat cardiovascular and renal diseases. |
|
| Products / Services |
Autologous blood management, ICD implantation, Pacemaker implantation, Heart surgery & CPB, Fibrin sealants, Extracorporeal circulation
|
|
| Market / Customers |
Atrial fibrillation, Bradyarrhythmia, Tachyarrhythmia, Heart Failure, Heart valve disease, Coronary artery disease
|
|
| Status |
| Shares in Sorin S.p.A. are listed on the Milan Stock Exchange. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
